Bruker Daltonics, Matritech, GPC Biotech, Applied Imaging, US Genomics | GenomeWeb

Bruker Reports Increased Revenues in Q1, Sells More Hybrid-FTMS Instruments

Bruker Daltonics of Billerica, Mass., reported revenues of $34.1 million for the first quarter of 2003, up from $25.7 million the year before.

The company recorded a net loss of $1.1 million ($0.02 per diluted share) for the quarter, compared with a net income of $900,000 ($0.02 per diluted share) during the same period last year. This loss is due to approximately $1.9 million in costs related to the company’s expected merger with Bruker AXS.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.